Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Both the FDA and EMA have approved the use of nivolumab in combination with fluoropyrimidine- and platinum-based chemotherapy for the first-line treatment of unresectable advanced, recurrent, or metastatic Esophageal squamous cell carcinoma (ESCC) with tumor cell PD-L1 expression of 1% or greater The regimen of cisplatin + 5‑FU is included in the CheckMate 648 program rather than being separately named in the label (1)
(1) [new-combin…